CRM Publications

Lehwald N, Duhme C, Wildner M, Kuhn S, Fürst G, Forbes SJ, Jonas S, Robson SC, Knoefel WT, Schmelzle M et al..  2014.  HGF and SDF-1-mediated mobilization of CD133+ BMSC for hepatic regeneration following extensive liver resection.Liver Int. 34(1):89-101.

Williams MJ, Clouston AD, Forbes SJ.  2014.  Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion.Gastroenterology. 146(2):349-56.

Boulter L, Govaere O, Bird TG, Radulescu S, Ramachandran P, Pellicoro A, Ridgway RA, Seo SSoo, Spee B, van Rooijen N et al..  2012.  Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease.Nat Med. 18(4):572-9.

Forbes SJ, Newsome PN.  2012.  New horizons for stem cell therapy in liver disease.J Hepatol. 56(2):496-9.

Thomas JA, Pope C, Wojtacha D, Robson AJ, Gordon-Walker TT, Hartland SN, Ramachandran P, Van Deemter M, Hume DA, Iredale JP et al..  2011.  Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.Hepatology. 53(6):2003-15.

Kallis YN, Robson AJ, Fallowfield JA, Thomas HC, Alison MR, Wright NA, Goldin RD, Iredale JP, Forbes SJ.  2011.  Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response.Gut. 60(4):525-33.

Hay DC.  2010.  Cadaveric hepatocytes repopulate diseased livers: life after death.Gastroenterology. 139(3):729-31.

Lorenzini S, Bird TG, Boulter L, Bellamy C, Samuel K, Aucott RL, Clayton E, Andreone P, Bernardi M, Golding M et al..  2010.  Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver.Gut. 59(5):645-54.

Kung JWC, Currie IS, Forbes SJ, Ross JA.  2010.  Liver development, regeneration, and carcinogenesis.J Biomed Biotechnol. 2010:984248.

Stutchfield BM, Rashid S, Forbes SJ, Wigmore SJ.  2010.  Practical barriers to delivering autologous bone marrow stem cell therapy as an adjunct to liver resection.Stem Cells Dev. 19(2):155-62.

Stutchfield BM, Forbes SJ, Wigmore SJ.  2010.  Prospects for stem cell transplantation in the treatment of hepatic disease.Liver Transpl. 16(7):827-36.

Dalgetty D, Medine C.N, Iredale JP, Hay DC.  2009.  Progress and future challenges in stem cell-derived liver technologies.Am J Physiol Gastrointest Liver Physiol. 297(2):G241-8.

Bird TG, Lorenzini S, Forbes SJ.  2008.  Activation of stem cells in hepatic diseases.Cell Tissue Res. 331(1):283-300.

Lieu H-T, Simon M-T, Nguyen-Khoa T, Kebede M, Cortes A, Tebar L, Smith AG, Bayne R, Hunt SP, Bréchot C et al..  2006.  Reg2 inactivation increases sensitivity to Fas hepatotoxicity and delays liver regeneration post-hepatectomy in mice.Hepatology. 44(6):1452-64.

Medvinsky AL, Smith A.  2003.  Stem cells: Fusion brings down barriers.Nature. 422(6934):823-5.